[1]
“The Use of LCZ-696 (Sacubitril/valsartan) and SGLT2inhibitors: A Real World Experience in a Rural African Patient with Heart Failure with Reduced Ejection Fraction (HFrEF). A Case Series”, GJMR, vol. 23, no. F1, pp. 1–10, Feb. 2023, doi: 10.34257/GJMRFVOL23IS1PG1.